BioAffinity Technologies- Warrants(23/06/2027) Profit Margin

BioAffinity Technologies- Warrants(23/06/2027) posts a profit margin of -257.33% as of June 2026. That compares with -152.18% in the prior-year period — down 69.1% year over year. That is below the sector sector average of 21.49%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioAffinity Technologies- Warrants(23/06/2027)'s profit margin was -152.18%. The latest reading is -257.33% — a 69.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 21.49% is typical. BioAffinity Technologies- Warrants(23/06/2027)'s -257.33% is lower that level. That is roughly 1297.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

BioAffinity Technologies- Warrants(23/06/2027)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -257.33% as of June 2026; use YoY and peer views to separate noise from signal.

Context for BIAFW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.49%), and (3) consistency with growth and profitability. This page covers the first two; BioAffinity Technologies- Warrants(23/06/2027)'s other metric pages and overview cover the third.